A resolution expressing the sense of the Senate that the scientific judgement of the Food and Drug Administration that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable and based on science.
About This Bill
Committee
Latest Action · December 14, 2023
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S6003-6004)